New avenues within community engagement: addressing the ingenuity gap in our approach to health research and future provision of health care

Journal of Responsible Innovation

Volumn 1, Issue 3, 2014, Pages 321-328

  Chalmers, Don ^a,b   McWhirter, Rebekah E ^a,b   Nicol, Dianne ^a   Whitton, Tess ^a,b   Otlowski, Margaret ^a,b   Burgess, Michael M ^c   Foote, Simon J ^d,f   Critchley, Christine ^a,e   Dickinson, Joanne L ^a,b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d MACQUARIE UNIVERSITY   (Australia)

^e SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^f Australian National University   (Australia)

Author keywords

biobanking; community consultation; deliberative democracy; personalised medicine; public engagement

Indexed keywords

EID: 85016760777     PISSN: 23299460     EISSN: 23299037     Source Type: Journal    
DOI: 10.1080/23299460.2014.963002     Document Type: Article

References (28)

1. Abelson, J., M., Giacomini, P., Lehoux, and F. P., Gauvin. 2007. “Bringing ‘The Public’ Into Health Technology Assessment and Coverage Policy Decisions: From Principles to Practice.” Health Policy 82 (1): 37–50.
2. ABS (Australian Bureau of Statistics). 2006. Adult Literacy and Life Skills Survey, Summary Results, Australia. 4228.0. Canberra: ABS.
3. ABS (Australian Bureau of Statistics). 2011. 2012. Population by Age and Sex, Regions of Australia. 3235.0. Canberra: ABS.
4. Brothers, CRD. 1964. “Huntington's Chorea in Victoria and Tasmania.” Journal of Neurological Science 1 (5): 405–420.
5. Burgess, J. R., R. A., Harle, P., Tucker, V., Parameswaran, P., Davies, T. M., Greenaway, and J. J., Shepherd. 1996. “Adrenal Lesions in a Large Kindred With Multiple Endocrine Neoplasia Type 1.” Archives of Surgery 131 (7): 699–702.
6. Burgess, M., K., O'Doherty, and D., Secko. 2008. “Biobanking in British Columbia: Discussions of the Future of Personalized Medicine Through Deliberative Public Engagement.” Personalized Medicine 5 (3): 285–296.
7. Chambers, S. 2003. “Deliberative Democracy Theory.” Annual Review of Political Science 6: 307–326. doi:10.1146/annurev.polisci.6.121901.085538
8. Chalmers, D., D., Nicol, M., Otlowski, and C., Critchley. 2013. “Personalised Medicine in the Genome era.” Journal of Law and Medicine 20 (3): 577–594.
9. Einseidel, E. F., E., Jelsøe, and T., Breck. 2001. “Publics at the Technology Table: The Consensus Conference in Denmark, Canada, and Australia.” Public Understanding of Science 10 (1): 83–89.
10. FitzGerald, L. M., B., Patterson, R., Thomson, A., Polanowski, S., Quinn, J., Brohede, T., Thornton et al. 2009. “Identification of a Prostate Cancer Susceptibility Gene on Chromosome 5p13q12 Associated With Risk of Both Familial and Sporadic Disease.” European Journal of Human Genetics 17 (3): 368–377.
11. Fung, A. 2003. “Survey Article: Recipes for Public Spheres: Eight Institutional Design Choices and Their Consequences.” The Journal of Political Philosophy 11 (3): 338–367.
12. Gaskell, G., and H., Gottweis. 2011. “Biobanks Need Publicity.” Nature 471 (7337): 159–160.
13. Gauvin, F.-P., J., Abelson, M., Giacomini, J., Eyles, and J. N., Lavis. 2010. “‘It All Depends’: Conceptualizing Public Involvement in the Context of Health Technology Assessment Agencies.” Social Sciences & Medicine 70 (10): 1518–1526.
14. Green, R. C., J. S., Berg, W. W., Grody, S. S., Kalia, B. R., Korf, C. L., Martin, A. L., McGuire et al. 2013. “ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing.” Genetics in Medicine 15 (7): 565–574.
15. Haddow, G., S., Cunningham-Burley, A., Bruce, and S., Parry. 2008. “Generation Scotland: Consulting Publics and Specialists at an Early Stage in a Genetic Database's Development.” Critical Public Health 18 (2): 139–149.
16. Laurie, G. 2011. “Reflexive Governance in Biobanking: On the Value of Policy Led Approaches and the Need to Recognise the Limits of Law.” Human Genetics 130 (3): 347–356.
17. Levitt, M. 2005. “UK Biobank: A Model for Public Engagement?” Genomics, Society and Policy 1 (3): 78–81.
18. Longstaff, H., and M. M., Burgess. 2010. “Recruiting for Representation in Public Deliberation on the Ethics of Biobanks.” Public Understanding of Science 19 (2): 212–224.
19. Mackey, D. A., 2012. “Genetic Eye Research in Tasmania: A Historical Overview.” Clinical & Experimental Ophthalmology 40 (2): 205–210.
20. Niemeyer, S. 2011. “The Emancipatory Effect of Deliberations: Empirical Lessons from Mini Publics.” Politics & Society 39 (1): 103–140.
21. O'Doherty, K. 2013. “Theorizing Deliberative Discourse.” In Public Engagement and Emerging Technologies, edited by K., O'Doherty, and E., Einseidel, 133–147. Vancouver: UBC Press.
22. O'Doherty, K. C., A. K., Hawkins, and M. M., Burgess. 2012. “Involving Citizens in the Ethics of Biobank Research: Informing Institutional Policy Through Structure Public Deliberation.” Social Science & Medicine 75 (9): 1604–1611.
23. Rowe, G., and L. J., Frewer. 2000. “Public Participation Methods: A Framework for Evaluation.” Science Technology & Human Values 25 (1): 3–29.
24. Rubio, J. P., M., Bahlo, H., Butzkueven, I. A., van Der Mei, M. M., Sale, J. L., Dickinson, P., Groom et al. 2002. “Genetic Dissection of the Human Leukocyte Antigen Region by Use of Haplotypes of Tasmanians with Multiple Sclerosis.” American Journal of Human Genetics 70 (5): 1125–1137.
25. Rychetnik, L., S. M., Carter, J., Abelson, H., Thornton, A., Barratt, V. A., Entwistle, G., Mackenzie, G., Salkeld, and P., Glasziou. 2013. “Enhancing Citizen Engagement in Cancer Screening Through Deliberative Democracy.” Journal of the National Cancer Institute 105 (6): 380–386.
26. Secko, D. M., M., Burgess, and K., O'Doherty. 2008. “Perspectives on Engaging the Public in the Ethics of Emerging Biotechnologies: From Salmon to Biobanks to Neuroethics.” Accountability in Research 15 (4): 283–302.
27. Van El, C. G., M. C., Cornel, P., Borry, R. J., Hastings, F., Fellmann, S. V., Hodgson, H. C., Howard et al. 2013. “Whole-genome Sequencing in Health Care.” European Journal of Human Genetics 21: 580–584. doi:10.1038/ejhg.2013.46
28. Winickoff, D. E., 2006. “Genome and Nation: Iceland's Health Sector Database and its Legacy.” Innovations: Technology, Governance, Globalization 1 (2): 80–105.